Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 6, 2024
Challenges and opportunities in the Polish healthcare sector from the implementation of telemedicine solutions in the field of gerontology and geriatric medicine: own experienceBeata Jankowska-Polańska, Bartosz Sapilak, Magdalena Kałuska, et al.
Behavioural Brain Research|April 18, 2020
IntelliCage as a tool for measuring mouse behavior - 20 years perspectiveAnna Kiryk, Artur Janusz, Bartosz Zglinicki, et al.
Scientific Reports|October 12, 2018
A generalised framework for detailed classification of swimming paths inside the Morris Water MazeAvgoustinos Vouros, Tiago V Gehring, Kinga Szydlowska, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2023
microRNA-449a reduces growth hormone-stimulated senescent cell burden through PI3K-mTOR signalingSarah Noureddine, Jia Nie, Augusto Schneider, et al.
Frontiers in Pharmacology|April 10, 2026
Preclinical evaluation of CPL423: a novel potent small-molecule inhibitor of TAM family and FLT3 kinase for cancer therapyAgata Mikołajczyk, Delfina Popiel, Kinga Jastrzębska, et al.
Bioorganic Chemistry|July 30, 2024
Unlocking the potential of higher-molecular-weight 5-HT7R ligands: Synthesis, affinity, and ADMET examinationPatryk Pyka, Sabrina Garbo, Aleksandra Murzyn, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric AgonistsPiotr Pankiewicz, Marcin Szybiński, Katarzyna Kisielewska, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 31, 2026
Identification of Pyrrolo[2,3-d]pyrimidine-Based Dual MERTK and FLT3 Inhibitor: Hit-to-Lead, Machine Learning, Modeling, Synthesis, and Biological EvaluationAbdellah Yamani, Paweł Maliszewski, Natalia Piórkowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Simultaneous 5-HT1BR agonist/5-HT6R antagonist action as a potential treatment of Parkinson's disease and its comorbiditiesPaweł Zajdel, Mikołaj Matłoka, Jolanta Konieczny, et al.
Pageof 1